Abstract
Midkine (MK) is a growth factor identified as a product of a retinoic acid-responsive gene. A truncated form of MK mRNA, which lacks a sequence encoding the N-terminally located domain, was recently found in cancer cells. We investigated the expression of the truncated MK mRNA in specimens of 47 surgically removed human gastrointestinal organs using polymerase chain reaction. Truncated MK was not detected in all of the 46 corresponding non-cancerous regions. On the other hand, this short MK mRNA was expressed in the primary tumours in 12 of 16 gastric cancers, 8 of 13 colorectal carcinomas, five of nine hepatocellular carcinomas, two of two oesophageal carcinomas and one ampullary duodenal cancer. In addition, truncated MK was detectable in all of the 14 lymph node metastases but in none of three metastatic sites in the liver, suggesting that truncated MK mRNA could become a good marker of nodal metastases in gastrointestinal tract.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aridome, K., Takao, S., Kaname, T. et al. Truncated midkine as a marker of diagnosis and detection of nodal metastases in gastrointestinal carcinomas. Br J Cancer 78, 472–477 (1998). https://doi.org/10.1038/bjc.1998.517
Issue date:
DOI: https://doi.org/10.1038/bjc.1998.517
This article is cited by
-
Diagnostic and predictive role of cell-free midkine in malignant pleural effusions
Journal of Cancer Research and Clinical Oncology (2013)
-
Tumor location determines midkine level and its association with the disease progression in colorectal cancer patients: a pilot study
International Journal of Colorectal Disease (2012)
-
Midkine mRNA Is Overexpressed in Pancreatic Cancer
Digestive Diseases and Sciences (2009)
-
Midkine as a prognostic biomarker in oral squamous cell carcinoma
British Journal of Cancer (2008)
-
Midkine is highly expressed in neuroblastoma tissues
Pediatric Surgery International (2008)


